FDA.reportPublic FDA data

NDC 86032-021 - Acyclovir

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
86032-021
Package NDCs from labels
86032-021-01
Manufacturer
Evereen Shanghai Biotechnology Ltd.
Effective date
2023-02-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
AcyclovirEvereen Shanghai Biotechnology Ltd.2023-02-08BULK INGREDIENT - ANIMAL DRUG

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 9 · 167 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACYCLOVIRACYCLOVIRBryant Ranch Prepacke5356160-cb35-4ff6-91d5-2ade594e02792026-03-25Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRBryant Ranch Prepack69e5455e-d0be-4c2b-b9ab-458b5480ed572026-03-16Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRREMEDYREPACK INC.8fdabab2-bc93-48ab-9c13-d22ec90fdcfc2026-02-27Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRFlorida Pharmaceutical Products, LLC3df7fa38-a869-45fb-98a3-81c5a2527d622026-02-18Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRMajor Pharmaceuticals46150f19-ce5d-42a0-80a7-f96fda2b98792026-02-18Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals, Inc.b6d69697-12bb-4548-a6c3-2463cbf54f8f2026-02-11Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRA-S Medication Solutions2e6a3667-af06-40de-80c0-8c4346e0671f2026-02-08Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRCamber Pharmaceuticals, Inc.0910335b-6796-459f-b97e-d7ef5439a0602026-02-02Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRGlenmark Pharmaceuticals Inc., USA149f4418-7668-4d34-a6f9-69bf3a9c50492026-01-28Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRANI Pharmaceuticals, Inc.8208711c-18ba-4615-b932-3c0bb7e6efae2026-01-23Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRActavis Pharma, Inc.a4c1305c-f18c-4fb0-83d8-2822341f2dfa2026-01-21Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals Inc75334fc5-d236-401a-875c-f4f9c7749c1a2026-01-19Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRPreferred Pharmaceuticals Incc11c1136-7421-48ff-86d2-39507e80a04c2026-01-15Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRPreferred Pharmaceuticals Inc.b1033fda-8242-4006-b1cd-23474d70671f2026-01-15Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRAvPAK6e203fa9-ee97-1e08-8d6a-fb57cfa13e192026-01-08Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRCadila Pharmaceuticals Limiteddbaf4bf5-57e3-4770-a9b2-d47649e54c1b2026-01-02Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRNorthwind Health Company, LLC5dcfd21c-43f0-469c-be70-a4e74e6ccf882026-01-01Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRNorthwind Health Company, LLCf6f56143-ea74-af87-e053-6394a90ae3462026-01-01Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
acyclovirACYCLOVIRNorthwind Health Company, LLCff9776b3-a248-e1ea-e053-6294a90aeb7b2026-01-01Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F
AcyclovirACYCLOVIRYILING PHARMACEUTICAL, INC.67e7b340-0635-2595-e053-2a91aa0ad2662025-12-30Warnings, Adverse reactionsExact identifier
unii: X4HES1O11F

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.